MCE - Delayed Quote EUR

Biotechnology Assets, S.A. (BST.MC)

Compare
0.3110
-0.0105
(-3.27%)
As of 1:40:22 PM GMT+2. Market Open.
Loading Chart for BST.MC
  • Previous Close 0.3215
  • Open 0.3210
  • Bid 0.3120 x --
  • Ask 0.3235 x --
  • Day's Range 0.3110 - 0.3260
  • 52 Week Range 0.2360 - 0.4200
  • Volume 17,150
  • Avg. Volume 197,837
  • Market Cap (intraday) 20.719M
  • Beta (5Y Monthly) 1.50
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 6, 2022
  • 1y Target Est --

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.

www.biatgroup.com

38

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BST.MC

View More

Performance Overview: BST.MC

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .

YTD Return

BST.MC
15.19%
IBEX 35... (^IBEX)
8.45%

1-Year Return

BST.MC
17.94%
IBEX 35... (^IBEX)
12.81%

3-Year Return

BST.MC
30.70%
IBEX 35... (^IBEX)
46.84%

5-Year Return

BST.MC
58.16%
IBEX 35... (^IBEX)
90.11%

Compare To: BST.MC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BST.MC

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    21.42M

  • Enterprise Value

    23.08M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.71

  • Price/Book (mrq)

    2.90

  • Enterprise Value/Revenue

    7.56

  • Enterprise Value/EBITDA

    84.00

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -90.49%

  • Return on Assets (ttm)

    -7.56%

  • Return on Equity (ttm)

    -40.78%

  • Revenue (ttm)

    3.37M

  • Net Income Avi to Common (ttm)

    -3.05M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    672.45k

  • Total Debt/Equity (mrq)

    34.31%

  • Levered Free Cash Flow (ttm)

    828.83k

Research Analysis: BST.MC

View More

Company Insights: BST.MC

Research Reports: BST.MC

View More

People Also Watch